Immunocore Holdings plc (IMCR) Misses Q3 EPS by 31c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of ($0.59), $0.31 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $51.49 million versus the consensus estimate of $50.69 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c